Patent details

Basic Information

Publication number:

EP2301535

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP111511267

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Immunological uses of immunomodulatory compounds for vaccine and anti-infectious disease therapy

French Title of Invention:

Utilisation immunologique de composés immunomodulateurs comme vaccin et thérapie pour des maladies infectieuses

German Title of Invention:

Immunologische Verwendungen von immunomodulatorischen Verbindungen zur Impfung und zur Therapie gegen Infektionskrankheiten

SPC Number:

Dates

Filing date:

31/08/2006

Grant date:

28/05/2014

EP Publication Date:

28/05/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/03/2011

EP B1 Publication Date:

28/05/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

31/08/2014

Expiration date:

31/08/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/08/2006

 

 

Name:

Celgene Corporation

Address:

86 Morris Avenue, Summit New Jersey 07901, United States (US)

Inventor

1

Name:

Muller George W.

Address:

United States (US)

2

Name:

Schafer Peter H.

Address:

United States (US)

3

Name:

Bartlett Justin B.

Address:

United States (US)

4

Name:

Meyer Brendan

Address:

United Kingdom (GB)

5

Name:

Galustian Christine

Address:

United Kingdom (GB)

6

Name:

Dalgleish Angus C.

Address:

United Kingdom (GB)

Priority

Priority Number:

712823 P

Priority Date:

01/09/2005

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/4035;

Filing date	Document type	Number of pages